USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
USANA Health Sciences, Inc.NYSE: USNA
EPS (Basic) · Q1 FY2026 · quarter ended Apr 2026
EPS (Basic) declines year over year
Q1 FY2026 EPS (Basic) of $0.41 fell 16.3% year over year, ahead of the -74.2% change in trailing-twelve-month EPS (Basic). Over 3 fiscal years it compounded at -45.6% a year.
Context
- EPS (Basic) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 1 analysts of $0.55 (-5.2%) for the fiscal year ending Jan 2027, a step up from the -73.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $0.41+522.7% QoQ
- Last fiscal yearJan 2026
- $0.58-73.6% YoY
- LTMApr 2026
- $0.47-74.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -16.3% | -17.3% | -1.0 pp |
| 1 year | -73.6% | -5.2% | +68.5 pp |
| 3-year CAGR | -45.6% | +42.5% | +88.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 0.58 USD
- Year-over-year change
- -73.6%
- 4-year CAGR
- -43.7%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 0.58 | -73.6% |
| FY2024 | 2024-12-28 | 2.20 | -33.9% |
| FY2023 | 2023-12-31 | 3.33 | -7.5% |
| FY2022 | 2022-12-31 | 3.60 | -37.7% |
| FY2021 | 2021-12-31 | 5.78 | — |
EPS (Basic) vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -74.2% is the 7th highest of 8, against a peer median of +17.6%.
- Over three fiscal years its annual growth of -45.6% compares with a peer median of +30.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | CN¥1.75 CNY | -2.1% | — | |
| LTM Mar 2026 | $0.99 USD | +43.6% | +147.5% | |
| LTM Apr 2026 | $0.47 USD | -74.2% | -45.6% | |
| LTM Apr 2026 | $0.15 USD | +35.3% | +30.6% | |
| LTM Mar 2026 | -$0.1 USD | -26.0% | — | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | -$0.75 USD | +17.6% | — |
| LTM Mar 2026 | -R$0.95 BRL | -117.4% | -35.8% | |
| LTM Apr 2026 | -$0.96 USD | +63.9% | — | |
| Peer median (excluding USNA) | — | +17.6% | +30.6% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 998.6M | 921.01M | 854.5M | 925.26M |
| Cost of Revenue | 230.93M | 207.28M | 189.4M | 175.75M | 200.85M |
| Gross Profit | 955.53M | 791.32M | 731.62M | 678.75M | 724.41M |
| Gross Margin | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| Research & Development | 11.11M | 11.56M | 11.45M | 11.57M | 0 |
| Selling, General & Admin | 774.23M | 672.14M | 627.1M | 600.86M | 337.37M |
| Operating Expenses | 785.34M | 683.7M | 638.54M | 612.43M | 673.54M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 39.7M |
| EBITDA | 192.89M | 130.22M | 123.11M | 98.86M | 82.07M |
| EBITDA Margin | 16.3% | 13.0% | 13.4% | 11.6% | 8.9% |
| Operating Income | 170.19M | 107.61M | 93.07M | 66.32M | 50.86M |
| Operating Margin | 14.3% | 10.8% | 10.1% | 7.8% | 5.5% |
| Interest Income | 2.52M | 3.79M | 9.64M | 11.32M | 2.42M |
| Interest Expense | 57K | 192K | 262K | 281K | 842K |
| Other Income / Expenses | 450K | 1.01M | 9.38M | 10.03M | (9.34M) |
| Income Before Tax | 170.64M | 108.62M | 102.45M | 76.35M | 41.53M |
| Pre-Tax Margin | 14.4% | 10.9% | 11.1% | 8.9% | 4.5% |
| Income Tax Expense | 54.14M | 39.27M | 38.67M | 34.29M | 30.05M |
| Net Income | 116.51M | 69.35M | 63.79M | 42.03M | 10.76M |
| Net Margin | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (Basic) | 5.78 | 3.60 | 3.33 | 2.20 | 0.58 |
| EPS (Diluted) | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
| Weighted Avg Shares | 20.15M | 19.25M | 19.25M | 19.06M | 18.57M |
| Weighted Avg Shares (Diluted) | 20.34M | 19.31M | 19.35M | 19.16M | 18.57M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.